Breaking News on Biopharmaceutical Development & Manufacturing

Headlines > Upstream Processing

Takeda prepping to take over EU production of stem cell therapy from 2021

23-Jun-2017 - Takeda says it is assessing manufacturing options ahead of potential European approval later this year of the Crohn’s disease stem cell therapy licensed from TiGenix.

TxCell hires Lentigen to make vectors used to produce its organ rejection cell therapy

20-Jun-2017 - TxCell SA has hired Lentigen Technology Inc. to make the vectors it uses to make its T-cell transplant rejection therapy.

Single-use in Ireland on the up? GE Healthcare, Thermo Fisher and NIBRT discuss the trend

20-Jun-2017 - Ireland’s “thriving biopharma industry ” has traditionally employed large-scale bioreactors, however a new wave of biologics with changing production requirements is changing the trend, say industry representatives.

Thermo Fisher opens single-use tech testing centre in UK

14-Jun-2017 - Thermo Fisher has opened a UK test centre to allow biopharmaceutical industry customers to test single-use production technologies.

GE Healthcare training facility opens in Ireland’s ‘thriving biopharma’ market

09-Jun-2017 - The National Institute for Bioprocessing Research and Training (NIBRT) has teamed up with GE Healthcare and opened a single-use focused training facility in Dublin, Ireland. 

Securing single-use systems: SSB opts for blockbuster resins and supplier partnerships

06-Jun-2017 - Single-use vendors must address their own supply chains to help overcome end-user challenges, says Sartorius.

Horizon and ATUM combine tech to offer stable cell line production

02-Jun-2017 - Horizon Discovery will add vector and transposase technology to its gene editing services through a cross-licensing partnership with gene and protein expression services firm ATUM.

Merck & Co. €280m spend in latest commitment to Irish biomanufacturing

31-May-2017 - Global demand for its biologics and vaccines has driven expansion plans and 300 jobs across two Irish facilities says MSD.

Lithuania's Biotechpharma jumps on the 2,000L single-use seed train

30-May-2017 -  Lithuanian CDMO Biotechpharma has completed a €15m ($16.7m) expansion adding more than 2,500L of single-use bioreactor capacity.

Merck rolls out cost cutting high density perfusion media

24-May-2017 - Merck has launched a culture media designed to make perfusion based drug production cheaper.

JSR Corporation invests $30m in CDMO facilities

24-May-2017 - JSR Corporation subsidiary KBI Biopharma is expanding its facilities in Durham, North Carolina and Boulder, Colorado, US, to respond to client needs.

GE looks to single-use modular BioParks to relieve capacity investment risk

23-May-2017 - Incorporating single-use and modular facilities into a vendor run bio-campus could reduce CAPEX spend dilemmas faced by drugmakers says GE Healthcare.

Dr Reddy’s turns to single-use for biosimilar production in India

19-May-2017 - Dr Reddy’s will expand its biosimilar manufacturing capacity in Hyderabad by 4,000L using GE Healthcare’s FlexFactory platform based on single-use technologies.

The automation generation: Sartorius integrates analytics tech

19-May-2017 - Sartorius Stedim Biotech (SSB) has announced it will combine technologies with US-based cell culture analysers Nova Biomedical, as a result of increased customer demand.

Therachon hires Catalent to make protein dwarfism drug for Ph I trial

19-May-2017 - Therachon AG has contracted Catalent Biologics to manufacture a candidate protein therapeutic for a rare form of dwarfism.

A happy medium for stem cells? Irvine Scientific launches GMP xeno-free offering

17-May-2017 - Xeno-free and cGMP-manufactured media are highly desired by cell therapy developers, says Irvine Scientific as it launches a medium for hematopoietic stem and progenitor cells (HSPCs).

Single-use making its mark in India as Stelis teams with MilliporeSigma

16-May-2017 - Stelis Biopharma has partnered with Germany’s Merck on a bioprocessing services centre in Bangalore and says single-use systems could kickstart India’s biomanufacturing sector.


How Thermo Fisher buying Patheon could simplify pharma supply chains

15-May-2017 - Thermo Fisher Scientific is set to buy contract manufacturer Patheon, but what would this mean for the life science tech firm?


Glenmark eyes up 1,000L production line expansion at Swiss plant

09-May-2017 - A second single-use production line could offer commercial-scale capacity for bispecific antibodies but Glenmark says it would need to scale-up further to support more traditional biologics.

News in brief

WuXi using Thermo Fisher to equip 28,000L single-use site in China

09-May-2017 - A WuXi Biologics facility tipped to be the world’s largest single-use mammalian cell culture site will be equipped with disposable systems from Thermo Fisher.

Juno hopes to make T Cells in two days using reagents and automation tech

05-May-2017 - Juno says it is working on a set of technologies which will be able to manufacture Chimeric Antigen Receptor (CAR) T Cells within two days.

Latest Avid investment to turn bioreactor capacity up to 11 (thousand litres)

03-May-2017 - Avid Bioservices will add multiple MilliporeSigma 2,000L bioreactors at its Californian single-use production plant in an effort to its increase annual revenue to over $100m.

Sartorius launches next-gen bioreactor range and pushes volume up to 2,000L

02-May-2017 - Satorius Stedim Biotech (SSB) has claimed its new bioreactors allowing in-process cell concentration measurement are an industry first.

BPI Europe 2017

Roche on excipient inconsistencies: ‘Don’t blame suppliers, work with them’

02-May-2017 - An inconsistent lot of excipient Poloxamer 188 cut biologic yield 30%, but working with supplier BASF was key to prevent future problems, according to Roche.

PharmaCell to make autologous cell therapies for Lion Biotech

28-Apr-2017 - Dutch contract manufacturer PharmaCell B.V has signed a three-year Manufacturing Services Agreement to make cancer cell therapies for Lion Biotechnologies.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...